Blepharospasm Clinical Trial
Official title:
Blepharospasm and the Experimental Modulation of Cortical Excitability in Primary and Secondary Motor Areas. A Pilot Study.
This research study will examine whether magnetic or electrical stimulation of the brain can
improve the involuntary closure of the eyelids in patients with blepharospasm or Meige
syndrome; conditions that belong to a group of neurological disorders called dystonias.
Blepharospasm and Meige syndrome cause excessive involuntary closure of the eyelids or
blinking. In an earlier study of patients with writer's cramp, which is another form of
dystonia, symptoms improved temporarily with brain stimulation.
Interested people 18 years of age or older with blepharospasm or Meige syndrome may be
eligible for this study. Candidates are screened with a medical history, physical examination
and a blink reflex test.
Participants undergo brain stimulation and evaluations before and after the stimulation to
test the response, as follows:
Procedures
- Transcranial magnetic stimulation (TMS): A wire coil is held on the patient's scalp. A
brief electrical current is passed through the coil, creating a magnetic pulse that
stimulates the brain. The subject hears a click and may feel a pulling sensation on the
skin under the coil. There may be a twitch in the muscles of the face, arm or leg. The
subject may be asked to tense certain muscles slightly or perform other simple actions.
The effect of TMS on the muscles is detected with small metal disk electrodes taped to
the skin of the arms or legs. TMS is done on eight of the ten test days.
- Repetitive TMS (rTMS): The same procedure as TMS, except repeated magnetic pulses are
delivered in short bursts. RTMS is done on eight of the ten test days.
- Theta burst stimulation (TBS): A form of rTMS that involves short bursts of impulses.
TBS is done on four study days.
- Cathodal transcranial DC stimulation (tDCS): Two conductive-rubber electrodes placed in
saline-soaked sponges are positioned over two areas of the head. A constant weak
electrical current flow is applied for 20 minutes. tDCS is done on two study days.
Evaluations
- Physician observation: The subject's eyes are videotaped for 5 minutes before and after
each TMS session. A physician then counts how many times the subject blinked during the
5 minutes.
- Questionnaire: Subjects are asked to rate their symptoms before and after brain
stimulation.
- Electrophysiological test of the blink reflex: Wires are taped to the skin on the nose
and temple to record the eye movement during blinking. A thin plastic rod is placed on
the skin over the right e...
BACKGROUND: Blepharospasm (BSP) is a common form of focal dystonia, but the etiology and
underlying pathophysiological mechanisms are still obscure. BSP is characterized by excessive
involuntary closure of the eyelids. Pathological changes in excitability in the primary motor
cortex (MC) and secondary motor areas, such as the anterior cingulate (AC), pre-and
supplementary cortex (PMC, SMA) are suggested from electrophysiological and brain imaging
studies. It is conceivable that modulation of excitability in some of these areas may lead to
amelioration of the symptoms of BSP. Cortical excitability can be experimentally changed by
various well-established electrophysiological techniques non-invasively.
METHODS: In this pilot protocol, studying 30 patients with BSP, we will use repetitive
transcranial magnetic stimulation (rTMS) over the AC, PMC, SMA and MC in two different
inhibitory modes: low frequency rTMS ((lf) rTMS) and continuous theta burst stimulation cTBS.
Furthermore, we will apply transcranial direct stimulation (tDCS) in an inhibitory mode
(cathodal tDCS) over the MC and low intensity high frequency supraorbital electrical
stimulation; the latter will be performed in patients and in 7 healthy subjects. The effects
on blepharospasm will be objectively measured by electrophysiological measures (blink reflex
recovery curve (BRR), blink rate observation by an investigator blinded to the intervention,
and a subjective rating by the patient.
OBJECTIVES: We hypothesize that we will find variable amounts of clinical improvement in BSP
patients with these different methods. With this study, we aim to get more insight to the
underlying pathophysiological mechanisms of BSP and identify which method of non-invasive
brain stimulation may be clinically most efficacious.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01686061 -
Blepharospasm Patient Survey for Patients With Blepharospasm
|
||
Completed |
NCT00535938 -
MDs on Botox Utility (MOBILITY)
|
N/A | |
Recruiting |
NCT05027997 -
Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm
|
Phase 2 | |
Terminated |
NCT03263000 -
Photic Blink Reflex in People With Blepharospasm and Increased Blinking
|
||
Completed |
NCT03938363 -
Analysis of Gait Before and After Botulinum Toxin Treatment in Patients With Focal Dystonia
|
N/A | |
Completed |
NCT02947815 -
Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm
|
Phase 2/Phase 3 | |
Completed |
NCT00406367 -
IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm
|
Phase 3 | |
Completed |
NCT00682760 -
Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm
|
Phase 3 | |
Completed |
NCT00210431 -
Post Marketing Surveillance Study of Dysport
|
||
Completed |
NCT05103202 -
Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin
|
||
Completed |
NCT04423341 -
Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm
|
Phase 2/Phase 3 | |
Completed |
NCT03269123 -
A Mechanical Device for Blepharospasm
|
N/A | |
Completed |
NCT00500799 -
Brain Changes in Blepharospasm
|
N/A | |
Completed |
NCT00761592 -
Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm
|
Phase 4 | |
Completed |
NCT00001784 -
Mexiletine for the Treatment of Focal Dystonia
|
Phase 2 | |
Recruiting |
NCT04939909 -
Botulinum Toxin Relieves Anxiety, Depression and Sleep Disorderes in Patients With Blepharospasm
|
Early Phase 1 | |
Completed |
NCT03508882 -
Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm
|
Phase 4 | |
Completed |
NCT01814774 -
A Retrospective Chart Review of BOTOX® and Xeomin® for the Treatment of Cervical Dystonia and Blepharospasm
|
N/A | |
Completed |
NCT00234507 -
Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm
|
Phase 2 | |
Recruiting |
NCT05618470 -
Wumeiwan Jiawei Fang Use in Patients With Blepharospasm
|
Phase 2/Phase 3 |